Detection of viable SARS-CoV-2 in deep respiratory specimens despite negative nasopharyngeal SARS-CoV-2 RT-PCR: Occult COVID-19 as an unsuspected cause of pulmonary infiltrates in immunocompromised patients. (2022)
- Record Type:
- Journal Article
- Title:
- Detection of viable SARS-CoV-2 in deep respiratory specimens despite negative nasopharyngeal SARS-CoV-2 RT-PCR: Occult COVID-19 as an unsuspected cause of pulmonary infiltrates in immunocompromised patients. (2022)
- Main Title:
- Detection of viable SARS-CoV-2 in deep respiratory specimens despite negative nasopharyngeal SARS-CoV-2 RT-PCR: Occult COVID-19 as an unsuspected cause of pulmonary infiltrates in immunocompromised patients
- Authors:
- Wee, Liang En
Tan, Jing Yuan
Ko, Karrie Kwan-Ki
Wan, Wei Yee
Lai, Deborah Chooi Mun
Oon, Lynette Lin Ean
Tan-Garcia, Alfonso
Yeong, Joe Poh Sheng
Pena, Angela Maria Takano
Lim, Tony Kiat Hon
Conceicao, Edwin Philip
Venkatachalam, Indumathi
Wijaya, Limin
Tan, Thuan Tong - Abstract:
- Abstract: Background: Prolonged shedding/relapse of COVID-19 infection has been reported, particularly in patients who received anti-CD20 agents (eg. rituximab). However, cases of occult COVID-19, in which SARS-CoV-2 persistence in lung parenchyma is diagnosed despite clearance from nasopharyngeal (NP) specimens, are uncommon. Case summary: We describe two cases of occult COVID-19 in immunocompromised patients. Both patients had received rituximab previously. Both cases initially presented as ground-glass infiltrates on lung imaging; the diagnosis was originally not suspected due to repeated demonstration of negative SARS-CoV-2 from NP specimens, and alternative etiologies were originally considered. Persistence of SARS-CoV-2 in lung parenchyma, however, was demonstrated on bronchoalveolar lavage (BAL) specimens; additionally, isolation of viable SARS-CoV-2 virus and detection of SARS-CoV-2 nucleocapsid and spike-protein antigen in lung tissue on immunohistochemistry close to 3-months from primary infection strongly suggested ongoing viral persistence and replication as a driver of the lung parenchymal changes, which resolved after antiviral treatment. Discussion: Occult COVID-19 can be a cause of unexplained ground-glass infiltrates on lung imaging; negative NP samples do not rule out SARS-CoV-2 persistence and invasive sampling must be considered. The unsuspected presence of viable virus on BAL, however, highlights that procedurists perfoming aerosol-generating-proceduresAbstract: Background: Prolonged shedding/relapse of COVID-19 infection has been reported, particularly in patients who received anti-CD20 agents (eg. rituximab). However, cases of occult COVID-19, in which SARS-CoV-2 persistence in lung parenchyma is diagnosed despite clearance from nasopharyngeal (NP) specimens, are uncommon. Case summary: We describe two cases of occult COVID-19 in immunocompromised patients. Both patients had received rituximab previously. Both cases initially presented as ground-glass infiltrates on lung imaging; the diagnosis was originally not suspected due to repeated demonstration of negative SARS-CoV-2 from NP specimens, and alternative etiologies were originally considered. Persistence of SARS-CoV-2 in lung parenchyma, however, was demonstrated on bronchoalveolar lavage (BAL) specimens; additionally, isolation of viable SARS-CoV-2 virus and detection of SARS-CoV-2 nucleocapsid and spike-protein antigen in lung tissue on immunohistochemistry close to 3-months from primary infection strongly suggested ongoing viral persistence and replication as a driver of the lung parenchymal changes, which resolved after antiviral treatment. Discussion: Occult COVID-19 can be a cause of unexplained ground-glass infiltrates on lung imaging; negative NP samples do not rule out SARS-CoV-2 persistence and invasive sampling must be considered. The unsuspected presence of viable virus on BAL, however, highlights that procedurists perfoming aerosol-generating-procedures during an ongoing pandemic wave must also practise appropriate infection-prevention precautions to limit potential exposure. … (more)
- Is Part Of:
- IDCases. Volume 30(2022)
- Journal:
- IDCases
- Issue:
- Volume 30(2022)
- Issue Display:
- Volume 30, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 30
- Issue:
- 2022
- Issue Sort Value:
- 2022-0030-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022
- Subjects:
- SARS-CoV-2 -- COVID-19 -- Viral antigen -- Relapse -- Immunocompromise -- Rituximab -- Occult COVID-19
Communicable diseases -- Periodicals
Communicable Diseases -- Case Reports
Communicable Diseases -- Periodicals
Communicable diseases
Periodicals
616.9 - Journal URLs:
- http://www.sciencedirect.com/science/journal/22142509 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.idcr.2022.e01611 ↗
- Languages:
- English
- ISSNs:
- 2214-2509
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24665.xml